Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Greiner

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Toxicologic Pathology|March 14, 2002
Laser technologies in toxicopathologyDanielle Roman, Brigitte Greiner, Merdol Ibrahim, et al.
Experimental Eye Research|June 9, 2005
Effects of antiglaucoma drugs timolol and GLC756, a novel dopamine D2 agonist and D1 antagonist, on endotoxin-induced-uveitis in ratsUlrich Wilhelm Laengle, Rudolf Markstein, Verena Schneider, et al.
ALTEX|January 1, 1991
[Discovery of novel immunosuppressants in vitro]Bernhard Ryffel, Gaetane Woerly, Gabriele Hofmann, et al.
BMC Public Health|September 24, 2024
Utilization frequency and patient-reported effectiveness of symptomatic therapies in post-COVID syndromeMiriam Reuner, Johannes Krehbiel, Jürgen Rech, et al.
International Journal of Environmental Research and Public Health|August 29, 2024
Three-Month Follow-Up of the Post-COVID Syndrome after Admission to a Specialised Post-COVID Centre-A Prospective Study Focusing on Mental Health with Patient Reported Outcome Measures (PROMs)Isabel Cecil Schäfer, Johannes Krehbiel, Werner Adler, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|January 6, 2004
Effects of epithelial growth factor receptor (EGFR) kinase inhibitors on genetically reconstituted mouse mammary glandsDaniel R Roth, Danielle Roman, Robert Cozens, et al.
Biochemical Pharmacology|November 6, 2003
LAV694, a new antiproliferative agent showing improved skin tolerability vs. clinical standards for the treatment of actinic keratosisJesús Medina, Valérie Picarles, Brigitte Greiner, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Toxicologic Pathology|March 14, 2002
Laser technologies in toxicopathologyDanielle Roman, Brigitte Greiner, Merdol Ibrahim, et al.
Experimental Eye Research|June 9, 2005
Effects of antiglaucoma drugs timolol and GLC756, a novel dopamine D2 agonist and D1 antagonist, on endotoxin-induced-uveitis in ratsUlrich Wilhelm Laengle, Rudolf Markstein, Verena Schneider, et al.
ALTEX|January 1, 1991
[Discovery of novel immunosuppressants in vitro]Bernhard Ryffel, Gaetane Woerly, Gabriele Hofmann, et al.
BMC Public Health|September 24, 2024
Utilization frequency and patient-reported effectiveness of symptomatic therapies in post-COVID syndromeMiriam Reuner, Johannes Krehbiel, Jürgen Rech, et al.
International Journal of Environmental Research and Public Health|August 29, 2024
Three-Month Follow-Up of the Post-COVID Syndrome after Admission to a Specialised Post-COVID Centre-A Prospective Study Focusing on Mental Health with Patient Reported Outcome Measures (PROMs)Isabel Cecil Schäfer, Johannes Krehbiel, Werner Adler, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|January 6, 2004
Effects of epithelial growth factor receptor (EGFR) kinase inhibitors on genetically reconstituted mouse mammary glandsDaniel R Roth, Danielle Roman, Robert Cozens, et al.
Biochemical Pharmacology|November 6, 2003
LAV694, a new antiproliferative agent showing improved skin tolerability vs. clinical standards for the treatment of actinic keratosisJesús Medina, Valérie Picarles, Brigitte Greiner, et al.
Pageof 1